文献速递免疫规划传染病防控与疫情报告

针对巴西流行的H1N1猪流感病毒的不同灭活重组疫苗在小鼠模型中的免疫与攻毒试验

Immunization and challenge trials in a murine model using different inactivated recombinant vaccines against H1N1 swine influenza virus circulating in Brazil.
PubMed 文献 · Vaccine · 2024-12-22

研究以反向遗传技术构建针对巴西猪群流行的huH1N1重组病毒,经灭活后分别配以水包油(OW)佐剂和凝胶聚合物(GP)佐剂制成疫苗。C57Bl6小鼠随机分为8组,间隔3周肌肉注射两剂,加强免疫后接种组血清转阳,攻毒后疫苗诱导保护。

要点

  • 用反向遗传技术构建huH1N1重组病毒并经灭活制备疫苗。
  • C57Bl6小鼠间隔3周肌肉注射两剂,加强后接种组血清转阳。
  • 攻毒后接种组疫苗诱导保护。

核心结论

  • 反向遗传技术可用于生产新的、快速更新的猪流感疫苗,有望控制巴西猪群中的病毒。
  • 未来研究可聚焦于利用该技术生产针对巴西猪群中不同SIAV毒株的多价重组疫苗。

研究设计与样本

  • 研究用反向遗传技术构建重组疫苗,并在小鼠模型中进行免疫与攻毒试验。
  • C57Bl6小鼠随机分为8组(G1-G8),间隔3周肌肉注射两剂:G1接种OW疫苗、G2接种PBS加OW佐剂、G3接种GP疫苗、G4接种PBS加GP佐剂、G5经鼻接种活病毒、G6仅接种PBS、G7和G8未接受任何处理。

主要发现

  • 除G8外,加强免疫三周后动物用野生huH1N1病毒攻毒并观察体重变化。
  • 加强免疫后接种组血清转阳,攻毒后疫苗诱导保护。
  • 攻毒后从各组动物采集支气管肺泡灌洗液(BALF)和肺组织,分别用于病毒滴度和免疫组化(IHC)分析。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In Brazil, at least four lineages of influenza A virus circulate pig population: 2009 H1N1 flu pandemic (pH1N1), human-seasonal origin H3N2, H1N1 and H1N2 (huH1 lineages) viruses. Studies related to the occurrence of swine influenza A virus (SIAV) in Brazilian herds have been detecting an increase of occurrence of huH1 lineages. This study aimed to construct recombinant vaccines against the huH1N1 virus and test the immunogens in a murine model. The virus was constructed by reverse genetics using plasmids encoding the HA and NA sequences from a wild huH1N1 virus isolated from an infected pig. Amplified virus was inactivated, and oil-in-water (OW) and gel polymer (GP) adjuvants were used to formulate the vaccines. C57Bl6 mice received two doses with 3 weeks interval by the intramuscular route. Animals were randomly divided into 8 groups (G1-G8): G1 received OW vaccine and G2 PBS plus OW adjuvant; G3 received GP vaccine and G4 PBS plus GP adjuvant; G5 received the live virus by the intranasal route while G6 only PBS; G7 and G8 did not receive any treatment. Serum samples were collected before vaccination and after the first and second dose. Except for G8, three weeks post boost animals were challenged with a wild huH1N1 virus and observed for weight changes. After infection, bronchoalveolar lavage fluid (BALF) and lungs were collected from animals of each group for viral titers and immunohistochemistry (IHC) analysis, respectively. After booster, vaccinated groups seroconverted and the vaccines induced protection upon challenge. Reverse Genetics technique can be used to produce new and quickly updated swine influenza vaccines which is promising to control the virus in Brazilian herds. Future studies may focus on using the technology to produce multivalent recombinant vaccines against distinct strains of SIAVs circulating in Brazilian pig herds.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Fraiha ALS, da Silva Santos BSÁ, Aguilar NR, et al. Immunization and challenge trials in a murine model using different inactivated recombinant vaccines against H1N1 swine influenza virus circulating in Brazil. Vaccine. 2024. PMID: 39709805. doi:10.1016/j.vaccine.2024.126638

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。